How can we understand today’s enormous increase in UI claims at the onset of the COVID-19 epidemic? Given how quickly the situation has moved we knew there would be a large increase in UI claims, whereas in a slower moving crisis, the weekly flows into UI slowly increase as the stock of UI claimants balloons. To put things in perspective we can go back to the Great Recession and accumulate UI claims in excess of what we would normally expect. The chart below shows that new UI claims in one week correspond to all new UI claims during the first six months of the Great Recession.

These statistics reflect public health policy aimed at slowing the spread of the disease. In terms of the labor market, if they also represent workers on temporary layoff, with their jobs kept intact and income support, we may see a V-shaped recovery. If, on the other hand, they represent workers that have now become truly unemployed, with their jobs terminated, and little income support, this will be a painful, slow, L-shaped recovery. As Ganong and Noel note elsewhere in these facts, UI claims may even undershoot the fraction of workers who would be eligible to claim.

More on this topic

BFI Data Studio·May 14, 2024

Return to Office and the Tenure Distribution

Austin Wright, David Van Dijcke, and Florian Gunsilius
Return-to-office (RTO) mandates drive employees away from firms, with senior employees leaving at the highest rates, likely leading to significant human capital costs in terms of output, productivity, innovation, and competitiveness for the companies implementing strict RTO policies.
Topics: COVID-19, Employment & Wages
Research Briefs·Mar 7, 2024

What Drives Inflation? Lessons from Disaggregated Price Data

Elisa Rubbo
US inflation in the early phases of the COVID pandemic was entirely driven by disruptions in supply and demand across industries, whereas most of the subsequent increase in consumer prices is driven by aggregate demand.
Topics: COVID-19, Monetary Policy
Research Briefs·Feb 1, 2024

Quantifying the Social Value of a Universal COVID-19 Vaccine and Incentivizing Its Development

Rachel Glennerster, Thomas Kelly, Claire T. McMahon, and Christopher M. Snyder
A universal COVID-19 vaccine that is effective against existing and future variants could provide the United States population with $1.5–$2.6 trillion more in social value than variant-specific boosters. The social value of a universal vaccine eclipses the cost of incentivizing...
Topics: COVID-19